Skip to content

Illumina ILMN Interest Expense

Interest Expense at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$401M
Azenta logo
AzentaAZTA
$4.39M-2.3%
Personalis, Inc. logo
Personalis, Inc.PSNL
$47K+67.9%
Guardant Health logo
Guardant HealthGH
$1.35M+70.3%
Natera, Inc. logo
Natera, Inc.NTRA
$892K-11.2%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Gross profit$770.0M+10.8%
Operating income$245.0M+14.5%
Net income$207.0M-11.9%
EPS (diluted)$1.35-9.4%

Balance sheet

See full
Cash & equivalents$1.0B+11.3%
Total debt$1.9B-7.3%
Total equity$2.8B+25.7%
Total assets$6.7B+9.2%

Cash flow

See full
Operating cash flow$201.0M-14.1%
CapEx$39.0M+30.0%
Free cash flow$162.0M-20.6%

Valuation

See full
Market cap$29.2B+69.7%
Enterprise value$30.1B+63.8%
P/E35.4×+21.7×
P/S6.5×+2.5×

Profitability

See full
Gross margin66.4%-0.2pp
Operating margin19.6%
Net margin18.4%-11.0pp
FCF margin20.7%-3.3pp

Returns & leverage

See full
Return on equity32.4%-35.7pp
Debt / equity0.7×-0.2×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's interest expense?
Illumina (ILMN) reported interest expense of $24M in Q1 2026.
How has Illumina's interest expense changed year-over-year?
Illumina's interest expense decreased by 4.0% year-over-year, from $25M to $24M.
What is the long-term trend for Illumina's interest expense?
Over 4 years (2021 to 2025), Illumina's interest expense has grown at a 13.0% compound annual growth rate (CAGR), from $62M to $101M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.